Brief Introduction
Our Clients
Our News
About Sinocro Partners

About Sinocro Partners
Sinocro Partners is a US merchant bank specialized in China healthcare and life science industry related investments and advisories. Sinocro partners provides advisory services in the area of china related investment, strategy, business development, government relationship, sale and marketing for both investment institutions and global life science industry leaders. Sinocro Partners has strong connections and execution capabilities of providing service related to medical affairs, preclinical and clinical developments, and research and discovery projects in China. Sinocro Partners also invest into life science companies and provide financial advisory related to fund raisings, and oversea IPOs.

Sinocro��s management team also has a unique combination of former high-level Chinese government officials, US consultants, US bankers, as well as Chinese industry leaders. Our combined business experiences from Pfizer, Mckinsey, Boston Consulting Group, Credit Suisse First Boston allow us to make the best judgments and advice for our clients.

Sinocro has formed broad partnerships with major research institution, biotech companies, and top Chinese pharmaceutical and biotech companies. Sinocro can help our client leverage the current existing manufacture, R&D, and sale and marketing coverage of state enterprise and local companies, and minimize upfront fix asset investment and operation cost.


版权所有 © 智特医疗
津ICP备 13002568 © All Rights Reserved.